Tailored Sonidegib Schedule After Complete Response in BCC

NCT04806646 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Basal Cell Carcinoma

Interventions

DRUG: Sonidegib

Sponsor

Gruppo Oncologico del Nord-Ovest